Source: BUSINESS WIRE

Press Release: Centrose : Research and Markets: Global Pancreatic Ductal Adenocarcinoma Therapeutics Development Pipeline Review, H1 2015 - 13 Companies & 22 Drug Profiles

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bjk5qr/pancreatic_ductal) has announced the addition of the "Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Pancreatic Ductal Adenocarcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
James R. Prudent's photo - President & CEO of Centrose

President & CEO

James R. Prudent

CEO Approval Rating

90/100

Read more